Detalles de la búsqueda
1.
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Oncologist
; 29(1): e118-e130, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603442
2.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520745
3.
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
Oncologist
; 27(2): e199-e202, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641202
4.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641222
5.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33988036
6.
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Oncologist
; 25(12): e1996-e2005, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557976
7.
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
Int J Mol Sci
; 21(5)2020 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111093
8.
Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results.
Chemotherapy
; 60(5-6): 294-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25999127
9.
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer.
Cancer Treat Rev
; 128: 102768, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797062
10.
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies.
Crit Rev Oncol Hematol
; 196: 104295, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382773
11.
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients.
Front Immunol
; 15: 1308109, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348046
12.
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.
Front Immunol
; 15: 1353889, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322260
13.
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.
Cancers (Basel)
; 14(22)2022 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428792
14.
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
J Thorac Oncol
; 17(9): 1086-1097, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659580
15.
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report.
Front Med (Lausanne)
; 8: 570921, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179028
16.
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Transl Lung Cancer Res
; 10(1): 202-220, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569305
17.
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?
Crit Rev Oncol Hematol
; 138: 87-103, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092389
18.
Retroperitoneal soft tissue sarcoma: prognostic factors and therapeutic approaches.
Tumori
; 94(4): 497-504, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18822685
19.
The role of tumor angiogenesis as a therapeutic target in colorectal cancer.
Expert Rev Anticancer Ther
; 18(3): 251-266, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29338550
20.
Successful Outflow Reconstruction to Salvage Traumatic Hepatic Vein-Caval Avulsion of a Normothermic Machine Ex-Situ Perfused Liver Graft: Case Report and Management of Organ Pool Challenges.
Medicine (Baltimore)
; 95(15): e3119, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27082550